Mycophenolic Acid
Showing 1 - 25 of 8,754
Informed preciSion doSIng tO iNdividualise and Optimize
Not yet recruiting
- Pharmacokinetics
- +4 more
- venipuncture
- (no location specified)
Oct 16, 2023
Specific Genotypes/Phenotypes of Pneumocystis Jirovecii in Solid
Not yet recruiting
- Transplantation
- Pulmonary Diseases
- (no location specified)
Jul 6, 2022
Liver Transplantation Trial in Los Angeles (Basiliximab, Tacrolimus, Mycophenolic Acid)
Completed
- Liver Transplantation
- Basiliximab
- +2 more
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Sep 14, 2022
Renal Insufficiency, Kidney Transplantation Trial in Amsterdam, Groningen, Leiden (tacrolimus OD, mycophenolic acid,
Completed
- Renal Insufficiency
- Kidney Transplantation
- tacrolimus OD, mycophenolic acid, prednisolone
-
Amsterdam, Netherlands
- +2 more
Dec 20, 2021
Renal Transplantation Trial (TCD601, belatacept, ATG)
Not yet recruiting
- Renal Transplantation
- TCD601
- +5 more
- (no location specified)
Dec 20, 2022
Kidney Transplantation, Kidney Transplant Rejection Trial in Los Angeles (Twice-daily Tacrolimus, Once-daily envarsus XR,
Recruiting
- Kidney Transplantation
- Kidney Transplant Rejection
- Twice-daily Tacrolimus
- +5 more
-
Los Angeles, CaliforniaUniversity of Southern California
Jun 6, 2022
Dry Eye Disease Trial in United States (SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium
Completed
- Dry Eye Disease
- SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
- +6 more
-
Phoenix, Arizona
- +39 more
Apr 10, 2022
Immunosuppression, Renal Failure Trial in Hershey (Arm A: Everolimus, Calcineurin Inhibitor)
Completed
- Immunosuppression
- Renal Failure
- Arm A: Everolimus
- Calcineurin Inhibitor
-
Hershey, PennsylvaniaPenn State College of Medicine; Penn State Milton S Hershey Medi
Jan 12, 2021
Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)
Active, not recruiting
- Carcinoma, Hepatocellular
- Everolimus
- +4 more
-
San Francisco, California
- +8 more
Jul 19, 2022
Patients Receiving MMF for Diffuse Cutaneous or Pulmonary
Recruiting
- Systemic Sclerosis
- AUC of MPA measure
-
Paris, FranceCochin hospital, AP-HP
Nov 19, 2021
Kidney Transplant Infection Trial in São Paulo (Sirolimus, Everolimus, Mycophenolic acid)
Completed
- Kidney Transplant Infection
- Sirolimus
- +2 more
-
São Paulo, Sao Paulo, BrazilHospital do Rim
Aug 23, 2021
Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)
Completed
- Severe Aplastic Anemia
- Bone Marrow Failure Syndromes
- Bone marrow transplant
- +7 more
-
Baltimore, Maryland
- +1 more
Feb 10, 2022
Kidney Transplantation Trial in Worldwide (AEB071, mycophenolic plus tacrolimus)
Terminated
- Kidney Transplantation
- AEB071
- mycophenolic plus tacrolimus
-
San Francisco, California
- +26 more
Dec 11, 2020
Kidney Transplant Trial in China (Tacrolimus immediate-release formulation, Tacrolimus prolonged-release formulation, Induction
Completed
- Kidney Transplant
- Tacrolimus immediate-release formulation
- +4 more
-
Beijing, China
- +13 more
Aug 3, 2022
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022
Kidney Transplantation Trial in Worldwide (AEB071, Mycophenolic Acid)
Completed
- Kidney Transplantation
- AEB071
- Mycophenolic Acid
-
San Francisco, California
- +27 more
Dec 11, 2020
Transplantation, Liver Trial in London, Newcastle (Biomarker, Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate
Active, not recruiting
- Transplantation, Liver
- Biomarker
- Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate mofetil or azathioprine
-
London, United Kingdom
- +1 more
Mar 10, 2021
High Probability of Poorly Responding to Therapy With
Completed
- Renal Transplantation
- MPA SNP
-
Vienna, AustriaDepartment of Medicine III, Division of Nephrology
Sep 9, 2020
Lupus Nephritis Trial in Worldwide (Mycophenolate Mofetil/Mycophenolic Acid, Obinutuzumab, Placebo)
Active, not recruiting
- Lupus Nephritis
- Mycophenolate Mofetil/Mycophenolic Acid
- +4 more
-
La Jolla, California
- +45 more
Nov 14, 2022
Renal Transplantation Trial in Worldwide (sotrastaurin (Dose 1) + tacrolimus + standard of care medications, sotrastaurin (Dose
Completed
- Renal Transplantation
- sotrastaurin (Dose 1) + tacrolimus + standard of care medications
- +3 more
-
Birmingham, Alabama
- +43 more
Dec 15, 2020
Kidney Transplant Rejection, Gastrointestinal Disorder, Functional Trial in Saint Louis (Everolimus, Mycophenolic Acid)
Terminated
- Kidney Transplant Rejection
- Gastrointestinal Disorder, Functional
- Everolimus
- Mycophenolic Acid
-
Saint Louis, MissouriWashington University
Aug 7, 2020
Disorder Related to Cardiac Transplantation Trial in Denmark, Norway, Sweden (Everolimus, Mycophenolic acid (MPA)/azathioprine
Completed
- Disorder Related to Cardiac Transplantation
- Everolimus
- +3 more
-
Arhus, Denmark
- +5 more
Jul 27, 2020
Predictors of Rejection in Pediatric Kidney Transplantation
Unknown status
- Rejection Acute Renal
- Tacrolimus capsule , mycophenolic acid
- (no location specified)
Feb 29, 2020
Kidney Failure Trial in Indianapolis (Tacrolimus, Everolimus)
Recruiting
- Kidney Failure
-
Indianapolis, IndianaIndiana University
Feb 4, 2020